Clinical Trial Update: Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing exenatide vs metformin monotherapy in overweight/obese patients with newly diagnosed type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• metformin (metformin)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Type2 Diabetes | Phase 4 | Status: COMPLETED